MATERIAL SAFETY DATA SHEET
BAYER CROPSCIENCE LP
P.O. Box 12014
2 T.W. Alexander Drive
Research Triangle Park, NC 27709
For Medical and Transportation Emergencies Only:
Call 24 hours a day 1-800-334-7577
For Product Use Information: Call 1-866-99BAYER (1-866-992-2937)
-------------------------------------------------------------------------------
1. CHEMICAL PRODUCT IDENTIFICATION:
-------------------------------------------------------------------------------
PRODUCT NAME........: AZTEC 2.1% Granular
PRODUCT CODE........: 11644
EPA REGISTRATION NO.: 264-754
CHEMICAL FAMILY.....: Organophosphorous & Pyrethroid Insecticides
CHEMICAL NAME.......: 0-(2-(1,1-Dimethylethyl)-5-pyrimidinyl) 0-ethyl
0-(1-methylethyl) phosphorothioate &
Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-
dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
SYNONYMS............: BAY MAT 7484 (tebupirimphos) & BAYTHROID (cyfluthrin)
FORMULA.............: C13 H23 N2 03 PS (tebupirimphos) & C22 H18 Cl2 F N 03
(cyfluthrin)
-------------------------------------------------------------------------------
2. COMPOSITION/INFORMATION ON INGREDIENTS:
-------------------------------------------------------------------------------
INGREDIENT NAME
/CAS NUMBER EXPOSURE LIMITS CONCENTRATION (%)
-------------------------------------------------------------------------------
-----------------------------------------
***** HAZARDOUS INGREDIENTS *****
-----------------------------------------
BAY MAT 7484 (tebupirimphos)
96182-53-5 OSHA : Not Established 2%
ACGIH: Not Established
------------------- ---------------------
BAYTHROID (cyfluthrin)
68359-37-5 OSHA : Not Established 0.1 %
ACGIH: Not Established
------------------- ---------------------
Total crystalline silica (quartz)
14808-60-7 OSHA : .10 mg/m3 TWA (respirable) 0 - 10 %
ACGIH: .10 mg/m3 TWA (respirable)
Product Code: 11644 MSDS Page 1
Approval date: 03/10/2003 Continued on next page
-------------------------------------------------------------------------------
3. HAZARDS IDENTIFICATION:
-------------------------------------------------------------------------------
*****************************************************************
* EMERGENCY OVERVIEW *
* *
*****************************************************************
POTENTIAL HEALTH EFFECTS:
ROUTE(S) OF ENTRY..................: Inhalation; Skin Contact; Skin Absorption;
Eye Contact
HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE:
ACUTE EFFECTS OF EXPOSURE.....: Inhalation, dermal absorption or ingestion of
the organophosphate insecticide contained in this formulation may result in
systemic intoxication due to inhibition of the enzyme cholinesterase. The
sequence of development of systemic effects varies with the route of entry,
and the onset of symptoms may be delayed up to 12 hours. First symptoms of
poisoning may be nausea, increased salivation, lacrimation, blurred vision
and constricted pupils. Other symptoms of systemic poisoning include
vomiting, diarrhea, abdominal cramping, dizziness and sweating. After
inhalation, respiratory symptoms like tightness of chest, wheezing, and
laryngeal spasms, may be pronounced at first. If the poisoning is severe,
then symptoms of convulsions, low blood pressure, cardiac irregularities,
loss of reflexes and coma may occur. In extreme cases, death may occur due
to a combination of factors such as respiratory arrest, paralysis of
respiratory muscles or intense bronchoconstrictions. Complete symptomatic
recovery from sublethal poisoning usually occurs within one week once the
source of exposure is completely removed. Skin irritation may occur from
contact with the pyrethroid insecticide contained in this formulation, and
produce symptoms such as itching, skin reddening or rash. Paresthesia (a
tingling or burning sensation on the surface of the skin) may also result
from skin contact. This is a frequently reported symptom associated with
sufficient dermal exposure to synthetic pyrethroids and normally subsides
without treatment within 24 hours. The onset of these symptoms usually
occurs 2-12 hours after exposure. Mucous membrane irritation involving the
nose, throat and upper respiratory tract may occur from inhalation of dust
during end use of the product such as an application. Based on EPA
Toxicity Category criteria, this product is moderately toxic orally and
mildly toxic dermally. In addition, animal studies have shown that it can
cause mild irritation to the conjunctiva of the eye with all irritation
resolving within 7 days, and that it is a slight dermal irritant.
CHRONIC EFFECTS OF EXPOSURE...: Cholinesterase inhibition sometimes persists
for 2-6 weeks, thus repeated exposure to small amounts of this material may
result in an unexpected cholinesterase depression causing symptoms such as
malaise, weakness, and anorexia that resemble other illnesses such as
influenza. Exposure to a concentration that would not have produced
symptoms in a person that was not previously exposed may produce severe
symptoms of cholinesterase inhibition in a previously exposed person. In
Product Code: 11644 MSDS Page 2
Approval date: 03/10/2003 Continued on next page
3. HAZARDS IDENTIFICATION (Continued)
---------------------------------------
addition, this product may contain an amount of total crystalline silica
(quartz) which ranges from 0 to 10%. However, the amount of respirable
crystalline silia is expected to be significantly lower based on data
provided by the raw material manufacturer. Excessive long-term exposure to
respirable crystalline silica may cause silicosis, a form of progressive
pulmonary fibrosis. Severe and permanent lung damage may result.
CARCINOGENICITY...............: AZTEC 2.1% is not listed as a carcinogen by NTP
or IARC, or regulated as a carcinogen by OSHA. However, it may contain
crystalline silica (quartz), a substance which is classified by NTP as a
Group 2 carcinogen and by IARC as a Group 2A carcinogen. Crystalline
silica is a naturally-occurring mineral component of many sands and clays.
Considerable controversy exists regarding the carcinogenic potential of
crystalline silica in humans, but based on animal data, the potential must
be considered relevant if crystalline silica is inhaled under excessive
exposure conditions. However, the respirable portion of the silica which
may be contained in this product is small, such that excessive inhalation
exposure during normal conditions of use is unlikely.
NTP.........................: Crystalline silica is classified as an NTP
Anticipated Human Carcinogen - "Substances or groups of substances that may
reasonably be anticipated to be carcinogens."
IARC........................: "IARC Monographs on the Evaluation of the
Carcinogenic Risk of Chemicals to Humans", Vol. 42 - for Crystalline Silica
(Quartz) - determined that "There is sufficient evidence for the
carcinogenicity of crystalline silica to experimental animals. There is
limited evidence for the carcinogenicity of crystalline silica to humans."
OSHA........................: Not regulated
MEDICAL CONDITIONS
AGGRAVATED BY EXPOSURE......: No specific medical conditions are known which
may be aggravated by exposure to the organophosphate insecticide contained
in this formulation; however, any disease, medication or prior exposure
which reduces normal cholinesterase activity may increase susceptibility to
the toxic effects of the active ingredient. As with any material which can
cause upper respiratory tract irritation, such as the pyrethroid
insecticide contained in this formulation, persons with a history of
asthma, emphysema, or hyperreactive airway disease, may be more susceptible
to overexposure. In addition, pulmonary and respiratory diseases may be
aggravated by exposure to respirable crystalline silica.
-------------------------------------------------------------------------------
4. FIRST AID MEASURES:
-------------------------------------------------------------------------------
FIRST AID FOR EYES......: Hold eyelids open and flush with copious amounts of
water for 15 minutes. Call a physician if irritation develops or persists
after flushing. If signs of intoxication (poisoning) occur, get medical
attention immediately.
Product Code: 11644 MSDS Page 3
Approval date: 03/10/2003 Continued on next page
4. FIRST AID MEASURES (Continued)
-----------------------------------
FIRST AID FOR SKIN......: Remove contaminated clothing. Wash skin immediately
with soap and water. Get medical attention if irritation develops or
persists. If signs of intoxication (poisoning) occur, get medical
attention immediately.
FIRST AID FOR INHALATION: If a person is overcome by excessive exposures to
dust of this material, remove to fresh air or uncontaminated area. If not
breathing, give artificial respiration, preferably mouth-to-mouth. Get
medical attention as soon as possible.
FIRST AID FOR INGESTION.: If ingestion is suspected, call a physician or poison
control center. Drink one or two glasses of water and induce vomiting by
touching back of throat with finger, or, if available, by administering
syrup of ipecac. If syrup of ipecac is available, administer 1
tablespoonful (15 mL) of syrup of ipecac followed by 1 to 2 glasses of
water. If vomiting does not occur within 20 minutes, repeat the dose once.
Do not induce vomiting or give anything by mouth to an unconscious person.
NOTE TO PHYSICIAN.......: This product contains tebupirimphos, a cholinesterase
inhibitor. Cholinesterase inhibition results in stimulation of the central
nervous system, the parasympathetic nervous system and the somatic motor
nerves. If symptoms of organophosphate poisoning are present, the
administration of atropine sulfate is indicated. Administer atropine
sulfate in large, therapeutic doses. In mild cases, start treatment by
giving 1-2 mg of atropine intravenously every 15 minutes until signs of
atropinization appear (dry mouth, flushing, and dilated pupils if pupils
were originally pinpoint). In severe cases, start treatment by giving 2-4
mg intravenously every 5-10 minutes until fully atropinized. Dosages for
children should be appropriately reduced. 2-PAM is also antidotal and may
be used in conjunction with atropine. Do not give morphine. Watch for
pulmonary edema which may develop in serious cases of poisoning even after
24 hours. At first sign of pulmonary edema, place patient in oxygen tent
and treat symptomatically. This product also contains cyfluthin, a
synthetic pyrethroid. Published data indicate vitabin E acetate can
prevent and/or mitigate symptoms of paresthesia caused by synthetic
pyrethroids. In case of poisoning, call the emergency number on page 1.
-------------------------------------------------------------------------------
5. FIRE FIGHTING MEASURES:
-------------------------------------------------------------------------------
FLASH POINT.....................: Not Applicable
FLAMMABLE LIMITS:
UPPER EXPLOSIVE LIMIT (UEL)(%): Not applicable
LOWER EXPLOSIVE LIMIT (LEL)(%): Not applicable
EXTINGUISHING MEDIA.............: Water; Dry Chemical
SPECIAL FIRE FIGHTING PROCEDURES: Keep out of smoke. Cool exposed containers
with water spray. Fight fire from upwind position. Use self-contained
breathing equipment. Contain runoff to prevent entry into sewers or
waterways. Equipment or materials involved in pesticide fires may become
contaminated.
Product Code: 11644 MSDS Page 4
Approval date: 03/10/2003 Continued on next page
-------------------------------------------------------------------------------
6. ACCIDENTAL RELEASE MEASURES:
-------------------------------------------------------------------------------
SPILL OR LEAK PROCEDURES..........: Isolate area and keep unauthorized people
away. Do not walk through spilled material. Avoid breathing dusts and
skin contact. Avoid generating dust (a fine water spray mist, plastic film
cover, or floor sweeping compound may be used if necessary). Use
recommended protective equipment while carefully sweeping up spilled
material. Place in covered container for reuse or disposal. Scrub
contaminated area with detergent and bleach solution. Rinse with water.
Use dry absorbent material such as clay granules to absorb and collect wash
solution for proper disposal. Contaminated soil may have to be removed and
disposed of. Do not allow material to enter streams, sewers, or other
waterways.
-------------------------------------------------------------------------------
7. HANDLING AND STORAGE:
-------------------------------------------------------------------------------
STORAGE TEMPERATURE(MIN/MAX): None/30 day average not to exceed 100 F
SHELF LIFE..................: Not Noted
SPECIAL SENSITIVITY.........: Heat, Moisture
HANDLING/STORAGE PRECAUTIONS: Store in a cool, dry area designated specifically
for pesticides. Do not store near any materials intended for use or
consumption by humans or animals.
-------------------------------------------------------------------------------
8. PERSONAL PROTECTION:
-------------------------------------------------------------------------------
EYE PROTECTION REQUIREMENTS........: Goggles should be used to prevent dust
from getting into the eyes.
SKIN PROTECTION REQUIREMENTS.......: Avoid skin contact. Wear long sleeves and
trousers. Use chemical-resistant gloves.
VENTILATION REQUIREMENTS...........: Maintain exposure levels below the
exposure limits through the use of general and local exhaust ventilation.
RESPIRATOR REQUIREMENTS............: Under normal conditions of use,
respiratory protection is not needed; however, if use conditions lead to
excessive concentrations of airborne dust, use a NIOSH-approved respirator
for dusts and mists or for pesticides.
ADDITIONAL PROTECTIVE MEASURES.....: Clean water should be available for
washing in case of eye or skin contamination. Educate and train employees
in safe use of the product. Follow all label instructions. Launder
clothing separately after use. Wash thoroughly after handling.
Product Code: 11644 MSDS Page 5
Approval date: 03/10/2003 Continued on next page
-------------------------------------------------------------------------------
9. PHYSICAL AND CHEMICAL PROPERTIES:
-------------------------------------------------------------------------------
PHYSICAL FORM.............: Granules
COLOR.....................: Gray, tan or reddish
ODOR......................: Slight onion-like odor
MOLECULAR WEIGHT..........: 318.4 for tebupirimphos; 434.3 for cyfluthrin
BOILING POINT.............: Not applicable
MELTING/FREEZING POINT....: Not applicable
SOLUBILITY IN WATER ......: 2 ppb for cyfluthrin; 5.5 ppm for tebupirimphos
SPECIFIC GRAVITY .........: Not Established
BULK DENSITY..............: 35-45 lb/cu. ft.
% VOLATILE BY VOLUME......: Not Established
VAPOR PRESSURE ...........: Not Established
VAPOR DENSITY ............: Not applicable (Air = 1)
-------------------------------------------------------------------------------
10. STABILITY AND REACTIVITY:
-------------------------------------------------------------------------------
STABILITY..................: This is a stable material.
HAZARDOUS POLYMERIZATION...: Will not occur.
INCOMPATIBILITIES..........: Strong oxidizers and bases; may react with
methanol.
INSTABILITY CONDITIONS.....: Not Noted
DECOMPOSITION PRODUCTS.....: Not established.
-------------------------------------------------------------------------------
11. TOXICOLOGICAL INFORMATION:
-------------------------------------------------------------------------------
Only acute studies have performed on this product as formulated. The non-acute
information pertains to the two active ingredients, cyfluthrin and
tebupirimphos.
ACUTE TOXICITY
ORAL LD50..........: Male rat: 190 mg/kg -- Female rat: 132 mg/kg
DERMAL LD50........: Male and Female Rabbit: >2000 mg/kg
INHALATION LC50....: 4 hr Exposure to Dust: Male Rat: >4.920 mg/l
(analytical) -- Female Rat: 2.860 mg/l (analytical); 1 hr Exposure to Dust
(extrapolated from 4 hr LC50): Male Rat: >19.68 mg/l (analytical) -- Female
Rat: 11.44 mg/l (analytical)
EYE EFFECTS........: Rabbit: Mild irritation to the conjunctiva was
observed with all irritation resolving within 7 days.
SKIN EFFECTS.......: Rabbit: Slight dermal irritant.
SENSITIZATION......: Guinea pig: Not a dermal sensitizer
SUBCHRONIC TOXICITY...: CYFLUTHRIN: In a 3 week dermal toxicity study,
cyfluthrin technical was administeted to rats for 6 hours/day at dose levels
Product Code: 11644 MSDS Page 6
Approval date: 03/10/2003 Continued on next page
11. TOXICOLOGICAL INFORMATION (Continued)
-------------------------------------------
of 100, 340 or 1000 mg/kg. Animals received a total of 17-18 applications in
a period of 22-23 days. An additional control and high-dose group were
treated and maintained for 14-15 days following treatment so as to ascertain
the extent of recovery. Effects observed included reduced feed consumption,
red nasal discharge, urine stains, and findings at the dose site (scabbing,
crusty, discolored and raised zones). Histologically, epidermal and dermal
alterations in treated skin were observed in animals of the mid- and high-dose
groups. Similar, but slightly less severe microscopic alterations were also
observed in the high-dose recovery group. The overall NOEL was 100 mg/kg. In
a 13 week inhalation study, rats were exposed to cyfluthrin at aerosol
concentrations of 0.09, 0.71 or 4.51 mg/m3 for 6 hours/day, 5 days/week. The
NOEL was 0.09 mg/m3 based on reduced body weight gains. TEBUPIRIMPHOS: In a
dermal toxicity study, rabbits were treated with tebupirimphos at levels of
0.3, 1.0, or 3.0 mg/kg for 6 hours/day, 5 days/week for 3 weeks.
Cholinesterase inhibition occurred at 1.0 mg/kg and greater with cholinergic
symptoms observed at the high dose. The no-observable-effect-level (NOEL) was
0.3 mg/kg. When rats were exposed via inhalation to tebupirimpphos at aerosol
concentrations of 0.16, 1.04 or 6.71 mg/m3 for 6 hours/day, 5 days/week for 4
weeks, the lowest-observable-effect-level (LOEL) was 1.04 mg/m3 based on
erythrocyte cholinesterse inhibition. The NOEL was 0.16 mg/m3.
CHRONIC TOXICITY......: CYFLUTHRIN: Cyfluthrin was administered for 2 years to
rats at dietary concentrations of 50, 150 or 450 ppm. Body weight gains were
reduced at 150 ppm and greater. The NOEL was 50 ppm based on reduced body
weight gains. Dogs were administered cyfluthrin for 1 year at dietary
concentrations of 40, 160 or 640 ppm. At the high dose, there was an increase
incidence of clinical signs and a reduction of body weight gains. The NOEL
was 160 ppm. Preliminary data are available on an ongoing dog study. Dogs
were administered cyfluthrin at dietary concentrations of 50, 100, 360 or 500
ppm for 1 year. Mid-term neurological examinations revealed hind-limb motor
distrubances at dose levels of 360 ppm and greater. TEBUPIRIMPHOS: In a 1
year feeding study on dogs, tebupirimhos was administered at dietary
concentrations of 0.2, 0.7 or 5.0 ppm. The LOEL was 5.0 ppm based on plasma,
erythrocyte, and brain cholinesterase inhibition. The NOEL was 0.7 ppm. Rats
were fed tebupirimphos for 2 years at dietary concentrations of 1, 5 or 25
ppm. The LOEL was 5 ppm on the basis of cholinesterase inhibition. The NOEL
for systemic effects were 1 ppm. In a 6 month supplemental cholinesterase
study using rats, 0.3 ppm was established as a statistical NOEL for
erythrocyte cholinesterase.
CARCINOGENICITY.......: CYFLUTHRIN: Cyfluthrin was investigated for
carcinogenicity in chronic studies using rats and mice at maximum levels of
450 and 800 ppm, respectively. There was no evidence of a carcinogenic
potential observed in either species. TEBUPIRIMPHOS: Tebupirimphos was
investigated for carcinogenicity in chronic studies using mice and rats.
There was no evidence of a carcinogenic potential of tebupirimphos in either
species.
MUTAGENICITY..........: CYFLUTHRIN: Numerous in vitro and in vivo mutagenicity
studies have been conducted on cyfluthrin, all of which are negative.
TEBUPIRIMPHOS: Numerous in vitro and in vivo mutagenicity studies have been
conducted on tebupirimphos, all of which are negative.
DEVELOPMENTAL TOXICITY: CYFLUTHRIN: In a developmental study using rats,
cyfluthrin was administered during gestation by oral gavage at doses ranging
Product Code: 11644 MSDS Page 7
Approval date: 03/10/2003 Continued on next page
11. TOXICOLOGICAL INFORMATION (Continued)
-------------------------------------------
from 1 to 30 mg/kg. The overall NOEL from these studies for maternal toxicity
was 3 mg/kg. No developmental effects were observed at any of the doses
tested. In each study the NOEL for developmental toxicity was equivalent to
the highest dose tested. The NOELs for developmental toxicity for the initial
study and the subsequent study were 30 and 10 mg/kg, respectively. Rabbits
were administered cyfluthrin during gestation by oral gavage at doses ranging
from 5 to 180 mg/kg. At maternally toxic levels, there was an increased
incidence of post-implantation losses. The overall NOEL derived from these
studies for both maternal and developmental toxicity was 20 mg/kg. In an
inhalation study, rats were exposed during gestation to cyfluthrin at aerosol
concentrations of 0.46, 2.55 or 11.9 mg/m3 for 6 hours/day. NOELs for
maternal and developmental toxicity were less than 0.46 and 0.46 mg/m3,
respectively. TEBUPIRIMPHOS: In a teratology study using rats,
tebupirimphos was administered orally at doses of 0.25, 0.5 and 0.75 mg/kg.
Fetotoxic and teratogenic effects were not observed at any dose. The maternal
NOEL was 0.5 mg/kg. When tebupirimphos was tested using rabbits at oral doses
of 0.03, 0.1 and 0.3 mg/kg, there was an increased incidence of resorptions at
the maternally toxic level of 0.3 mg/kg. Teratogenic effects were not
observed at any dose. The NOEL for both embryo- and maternal toxicity was 0.1
mg/kg.
REPRODUCTION..........: CYFLUTHRIN: In a reproduction study, cyfluthrin was
administered to rats for 3 generations at dietary concentrations of 50, 150
and 450 ppm. Reproductive effects observed at parentally toxic levels
included reductions in viability, lactation, litter size, feed consumption,
and pup birth weights and body weight gains. Coarse tremors were observed in
some offspring at 450 ppm. The NOEL for both parental and reproductive
effects was 50 ppm. In another reproduction study, cyfluthrin was
administered to rat s for 2 generations at dietary concentrations of 50, 125
or 400 ppm. Coarse tremors occurring in conjunction with parental toxicity
were observed in the offspring in the mid- and high-dose groups. Based on
this finding, the neonatal NOEL was 50 ppm. The NOELs for parental and
reproductive toxicity were 50 and 400 ppm, respectively. TEBUPIRIMPHOS:
Tebupirimphos was investigated in a 2 generation reproductive study in rats at
dietary concentrations of 1, 5 and 25 ppm. Reproductive effects occurred at
the maternally toxic level of 25 ppm. These effects included decreased
fertility rates in adults and cholinesterase inhibition, behavorial changes
and decreased growth and survival rates in the offspring. The reproductive
NOEL was 5 ppm.
NEUROTOXICITY ........: CYFLUTHRIN: Numerous neurotoxicity studies have been
conducted on cyfluthrin. Oral gavage studies using hens, have indicated that
at extremely high dose levels (5000 mg/kg), minimal nerve damage occurs. When
rats were administered cyfluthrin daily at oral doses of 40 to 80 mg/kg for 14
days, minimal nerve effects were seen. These effects were completely
reversible within a 3 month recovery period. In dermal and inhalation studies
which are more relevant to field exposure, there was no evidence of delayed
neurotoxicity in hens. In special investigative studies, litters of neonatal
mice (10 days of age) and their mothers were exposed via inhalation to
cyfluthrin in whole body chambers. The mice were exposed to aerosol
concentrations ranging from 0.1 to 50 mg/m3 for 6.3 hours/day for 7 successive
days. At 4 months of age or approximately 3.5 months after exposure, motor
activity was measured in the offspring. At 50 mg/m3, all of the offsprings
Product Code: 11644 MSDS Page 8
Approval date: 03/10/2003 Continued on next page
11. TOXICOLOGICAL INFORMATION (Continued)
-------------------------------------------
died or were sacrificed in a moribund state following the first exposure.
Mortalities were not observed at any of the other levels. In addition,
preliminary results indicate a possible increase in motor activity in 4 month
old female mice at exposure levels of 10 mg/m3 and greater. TEBUPIRIMPHOS:
There was no evidence of a neurotoxic effect in antidote protected hens
treated by oral gavage at 10 mg/kg with tebupirimphos. In an acute
neurotoxicity study using rats, tebupirimphos was administered as a single
oral dose at analytically confirmed levels of 0.5, 2 or 5 mg/kg for males and
0.3, 0.5 and 1 mg/kg for females. All clinical signs and neurobehavorial
effects were ascribed to acute cholinergic toxicity, and with complete
recovery in surviving animals within 14 days following treatment. Excluding
cholinergic responses, the NOEL for neurotoxicity is 5 mg/kg for males and 1
mg/kg for females (highest dose tested). In a 13 week neurotoxicity study,
tebupirimphos was administered to rats at dietary concentrations of 4 , 16 or
60 ppm for males and 4, 12 or 40 ppm for females. All clinical signs and
neurobehavioral effects observed were ascribed to cholinergic toxicity,
occurring at exposure levels that produced substantial inhibition of
cholinesterase activity. There were no correlative micropathologic findings
within the neural tissues or skeletal muscle. Excluding cholinergic
responses, the NOEL for neurotoxicity was 60 ppm for males and 40 ppm for
females (highest doses tested.
-------------------------------------------------------------------------------
12. ECOLOGICAL INFORMATION:
-------------------------------------------------------------------------------
NO ECOLOGICAL INFORMATION AVAILABLE
-------------------------------------------------------------------------------
13. DISPOSAL CONSIDERATIONS
-------------------------------------------------------------------------------
WASTE DISPOSAL METHOD.......: Follow container label instructions for disposal
of wastes generated during use in compliance with the FIFRA product label.
In other situations, bury in an EPA approved landfill or burn in an
incinerator approved for pesticide destruction. Do not reuse container.
-------------------------------------------------------------------------------
14. TRANSPORTATION INFORMATION:
-------------------------------------------------------------------------------
TECHNICAL SHIPPING NAME........: Tebupirimphos & Cyfluthrin
FREIGHT CLASS BULK.............: Insecticide, NOI (NMFC 102120)
FREIGHT CLASS PACKAGE..........: Insecticide, NOI (NMFC 102120)
PRODUCT LABEL..................: Not Noted
Product Code: 11644 MSDS Page 9
Approval date: 03/10/2003 Continued on next page
14. TRANSPORTATION INFORMATION (Continued)
--------------------------------------------
DOT (DOMESTIC SURFACE)
----------------------
PROPER SHIPPING NAME...........: Organophosphorus Pesticide, Solid, Toxic
HAZARD CLASS OR DIVISION ......: 6.1
UN/NA NUMBER...................: UN2783
PACKING GROUP .................: III
DOT PRODUCT RQ lbs (kgs).......: None
HAZARD LABEL(s)................: Keep Away From Food
HAZARD PLACARD(s)..............: Keep Away From Food
IMO / IMDG CODE (OCEAN)
-----------------------
PROPER SHIPPING NAME...........: Organophosphorus Pesticide, Solid, Toxic
HAZARD CLASS DIVISION NUMBER...: 6.1
UN NUMBER......................: UN2783
PACKAGING GROUP................: III
HAZARD LABEL(s)................: Keep Away From Food
HAZARD PLACARD(s)..............: Keep Away From Food
ICAO / IATA (AIR)
-----------------
PROPER SHIPPING NAME...........: Organophosphorus Pesticide, Solid, Toxic
HAZARD CLASS DIVISION NUMBER...: 6.1
UN NUMBER......................: UN2783
SUBSIDIARY RISK................: None
PACKING GROUP..................: III
HAZARD LABEL(s)................: Keep Away From Food
RADIOACTIVE?...................: Non-Radioactive
-------------------------------------------------------------------------------
15. REGULATORY INFORMATION:
-------------------------------------------------------------------------------
OSHA STATUS.................: This product is hazardous under the criteria of
the Federal OSHA Hazard Communication Standard 29
CFR 1910.1200.
TSCA STATUS.................: This product is exempt from TSCA Regulation under
FIFRA Section 3 (2)(B)(ii) when used as a
pesticide.
CERCLA REPORTABLE QUANTITY..: No components listed.
SARA TITLE III:
SECTION 302 EXTREMELY
HAZARDOUS SUBSTANCES..: No components listed.
SECTION 311/312
HAZARD CATEGORIES.....: Immediate Health Hazard; Delayed Health Hazard
SECTION 313
TOXIC CHEMICALS.......: Cyfluthrin (0.1%) - CAS #68359-37-5
RCRA STATUS.................: If discarded in its purchased form, this product
would not be a hazardous waste either by listing
Product Code: 11644 MSDS Page 10
Approval date: 03/10/2003 Continued on next page
15. REGULATORY INFORMATION (Continued)
----------------------------------------
or by characteristic. However, under RCRA, it is
the responsibility of the product user to
determine at the time of disposal, whether a
material containing the product or derived from
the product should be classified as a hazardous
waste. (40 CFR 261.20-24)
-------------------------------------------------------------------------------
16. OTHER INFORMATION:
-------------------------------------------------------------------------------
NFPA 704M RATINGS: Health Flammability Reactivity Other
2 1 0
0=Insignificant 1=Slight 2=Moderate 3=High 4=Extreme
Bayer鈥檚 method of hazard communication is comprised of Product Labels and
Material Safety Data Sheets. NFPA ratings are provided by Bayer as a customer
service.
REASON FOR ISSUE..........: Revise Section 4(Note to Physician)and Section 16
(Other Information)
PREPARED BY...............: C. A. Sheehan
APPROVED BY...............: S. E. Earnest
TITLE.....................: Manager, Quality Systems Services
APPROVAL DATE.............: 03/10/2003
SUPERSEDES DATE...........: 02/28/2003
MSDS NUMBER...............: 08625
-------------------------------------------------------------------------------
This information is furnished without warranty, expressed or implied, except
that it is accurate to the best knowledge of Bayer CropScience. The data on
this sheet relates only to the specific material designated herein. Bayer
CropScience assumes no legal responsibility for use or reliance upon these
data.
-------------------------------------------------------------------------------
Product Code: 11644 MSDS Page 11
Approval date: 03/10/2003 Last page
|